The association between symptomatic, severe hypo- glycaemia and mortality in type 2 diabetes: retrospective epidemio- logical analysis of the ACCORD study. BMJ. 2010;340:b4909. 186. ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560 2572. doi: 10.1056/ NEJMoa0802987. 187. Control Group, Turnbull FM, Abraira C, Anderson RJ, Anderson RJ, Byington RP, Chalmers JP, Duckworth WC, Evans GW, Gerstein HC, Holman RR, Moritz TE, Neal BC, Ninomiya T, Patel AA, Paul SK, Travert F, Woodward M. Intensive glucose control and macrovascular outcomes in type 2 diabetes [published cor- rection appears in Diabetologia. 2009;52:2470]. Diabetologia. 2009;52:2288 2298. doi: 10.1007/s00125-009-1470-0. 188. Kooy A, de Jager J, Lehert P, Bets D, Wulffel MG, Donker AJ, Stehouwer CD. Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus. Arch Intern Med. 2009;169:616 625. doi: 10.1001/archinternmed.2009.20. 189. Alexander JK. Obesity and the heart. Heart Dis Stroke. 1993;2:317 321. 190. Alpert MA, Terry BE, Mulekar M, Cohen MV, Massey CV, Fan TM, Panayiotou H, Mukerji V. Cardiac morphology and left ventricu- lar function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss. Am J Cardiol. 1997;80:736 740. 191. Seide MJ. Heart failure due to extreme obesity; report of a case, with autopsy findings. N Engl J Med. 1957;257:1227 1230. 192. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS. 